HilleVax Announces Pricing of Upsized Initial Public Offering
April 28, 2022 21:03 ET
|
HilleVax, Inc.
BOSTON, April 28, 2022 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the...